Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sarda ProteinsBOM:519242 +5.00%65 PB Ratio is 30.40 as of Sep. 09, 2026, which is 1618% above its 10-year median of 1.77. GuruFocus rates BOM:519242 with a GF Score™ of 65/100 and a GF Value™ of ₹117.60 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,912 Consumer Packaged Goods companies, Sarda Proteins ranks worse than 92.73% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-09), Sarda Proteins's share price is ₹102.15. Sarda Proteins's Book Value per Share for the quarter that ended in Jun. 2026 was ₹3.36. Hence, Sarda Proteins's PB Ratio of today is 30.40.
The historical rank and industry rank for Sarda Proteins's PB Ratio or its related term are showing as below:
BOM:519242'
s PB Ratio Range Over the Past 10 Years
Min: 0.3 Med: 1.77 Max: 20.73
Current: 7.42
During the past 13 years, Sarda Proteins's highest PB Ratio was 20.73. The lowest was 0.30. And the median was 1.77.
BOM:519242's PB Ratio is ranked worse than 92.73% of 1912
companies
in the Consumer Packaged Goods industry
Industry Median: 1.43
vs BOM:519242: 7.42
During the past 3 years, the average Book Value Per Share Growth Rate was -0.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 1.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Sarda Proteins was 30.70% per year. The lowest was -14.00% per year. And the median was 0.85% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sarda Proteins PB Ratio Related Terms
Sarda Proteins PB Ratio Historical Data
* Premium members only.
The historical data trend for Sarda Proteins's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Sarda Proteins's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sarda Proteins PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sarda Proteins's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sarda Proteins's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Sarda Proteins's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sarda Proteins (BOM:519242) has a PB Ratio of 30.40 as of Sep. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sarda Proteins and its competitors. This is 1618% above median its historical median of 1.77. Over the past decade, Sarda Proteins' PB Ratio has ranged from 0.30 to 20.73. According to the industry distribution chart, Sarda Proteins ranks #1773 out of 1912 companies in the Consumer Packaged Goods industry, placing it in the top 92.7%.
Is Sarda Proteins' PB Ratio too high?
Sarda Proteins' current PB Ratio of 30.40 is 1618% above median its 10-year median of 1.77. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 20.73. The Consumer Packaged Goods industry median PB Ratio is 1.43. Sarda Proteins' value of 30.40 is 2025.9% above this industry median. Based on the distribution chart, Sarda Proteins ranks #1773 out of 1912 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Sarda Proteins has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sarda Proteins' PB Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Sarda Proteins ranks #1773 out of 1912 companies for PB Ratio. This places Sarda Proteins in the lower half of its industry. The industry median PB Ratio is 1.43. Sarda Proteins' value of 30.40 is 2025.9% above this benchmark. Historically, Sarda Proteins' own PB Ratio has ranged from 0.30 to 20.73 over the past decade. While the company's 10-year median is 1.77 vs. the industry median of 1.43, Sarda Proteins has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.43, based on 1,912 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sarda Proteins's current PB Ratio of 30.40 is 2025.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sarda Proteins and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sarda Proteins's current PB Ratio is 30.40, which is 1618% above median its own 10-year median of 1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sarda Proteins stock overvalued right now?
Based on GuruFocus' analysis, Sarda Proteins (BOM:519242) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹117.60, compared to a current price of ₹102.15 — trading 13.1% below its estimated fair value. The current PB Ratio is 30.40, which is 1618% above median its 10-year median of 1.77 and 2025.9% above the Consumer Packaged Goods industry median of 1.43. Sarda Proteins' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sarda Proteins (BOM:519242), the current PB Ratio is 30.40 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sarda Proteins (BOM:519242) Overvalued in 2026?
Based on GuruFocus' analysis, Sarda Proteins stock appears to be undervalued.
The current stock price of ₹102.15 is trading 13.1% below its estimated GF Value™ of ₹117.60.
GuruFocus considers Sarda Proteins to be Modestly Undervalued.
Key valuation signals for BOM:519242:
PB Ratio: 30.40 (1618% above median its 10-year median of 1.77)
GF Value™: ₹117.60 vs. price of ₹102.15 (13.1% below fair value)
Industry Position: 2025.9% above the Consumer Packaged Goods median (#1773 of 1912)
No single metric tells the full story. See the BOM:519242 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sarda Proteins Ltd is a dynamic company driving innovation in renewable energy, with core expertise in solar plant services, carbon-credit markets, intelligent asset management, and automation technologies. The company mainly deals in the trading of solar cells. It has only one segment, i.e., Renewable Energy Sector Solar Cell Products.
65GF Score
Get the complete analysis for BOM:519242
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:519242 has been successfully added to your 
